Success Metrics

Clinical Success Rate
93.3%

Based on 14 completed trials

Completion Rate
93%(14/15)
Active Trials
1(6%)
Results Posted
50%(7 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_4
5
28%
Ph phase_2
3
17%
Ph phase_3
7
39%
Ph not_applicable
3
17%

Phase Distribution

0

Early Stage

3

Mid Stage

12

Late Stage

Phase Distribution18 total trials
Phase 2Efficacy & side effects
3(16.7%)
Phase 3Large-scale testing
7(38.9%)
Phase 4Post-market surveillance
5(27.8%)
N/ANon-phased studies
3(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.3%

14 of 15 finished

Non-Completion Rate

6.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

18

all time

Status Distribution
Active(1)
Completed(14)
Terminated(1)
Other(2)

Detailed Status

Completed14
unknown2
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
1
Success Rate
93.3%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (16.7%)
Phase 37 (38.9%)
Phase 45 (27.8%)
N/A3 (16.7%)

Trials by Status

terminated16%
completed1478%
recruiting16%
unknown211%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT07099157Phase 4

Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster

Recruiting
NCT05283551Phase 2

Famciclovir in Multiple Sclerosis

Unknown
NCT00878072Phase 2

Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis

Completed
NCT01281007Phase 3

Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes

Completed
NCT01526408Phase 3

Famvir for Treatment of Hearing in Unilateral Meniere's Disease

Terminated
NCT01327144Phase 3

Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster

Completed
NCT01321515Not Applicable

Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions

Completed
NCT01321502Not Applicable

Bioequivalency Study of Famciclovir 500 mg Tablets Under Fed Conditions

Completed
NCT03120962Not Applicable

Effect of Early Use of Oxycodone During the Acute Phase of Herpes Zoster on Preventing Postherpetic Neuralgia

Unknown
NCT00171990Phase 3

Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital Herpes

Completed
NCT00098059Phase 3

Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection

Completed
NCT00219310Phase 4

RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir

Completed
NCT00129818Phase 4

A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding

Completed
NCT00306787Phase 3

Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes

Completed
NCT00477334Phase 4

Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients

Completed
NCT00448227Phase 2

Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection

Completed
NCT00248144Phase 4

A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis

Completed
NCT00098046Phase 3

Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18